Brief: Innovent Announces 2026 Interim Results And Business Updates
25/08/2026 12:44
BRIEF-Innovent Announces 2026 Interim Results And Business Updates Aug 25 (Reuters) - Innovent Biologics, Inc. 1801.HK:
INNOVENT ANNOUNCES 2026 INTERIM RESULTS AND BUSINESS UPDATES
Source text: ID:nPn4vSzra
Further company coverage: 1801.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innovent Biologics
See all newsChina emerges as obesity drug lab for Big Pharma
Eli Lilly becomes first drugmaker to have a GLP-1 weight-loss pill approved in China (updated)
China emerges as obesity drug lab for Big Pharma
Pfizer raises 2026 forecasts as Eliquis, cancer drugs drive third-quarter results (updated)
Refile: Pfizer raises 2026 forecast on strong demand for blood thinner Eliquis